[New trends in therapy for leukemia: Approach from the point of view of molecular information].
Ueda
Ryuzo
R
D001549:Benzamides; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl; D018390:Gene Targeting; D006801:Humans; D000068877:Imatinib Mesylate; D007938:Leukemia / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D025202:Molecular Diagnostic Techniques; D010879:Piperazines / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl